These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7227446)

  • 81. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Early-onset thrombocytopenia in the chemotherapy of testicular teratoma.
    Pedrazzini A; Cavalli F; Kiser J; Goldhirsch A
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):867. PubMed ID: 6191990
    [No Abstract]   [Full Text] [Related]  

  • 83. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Delgado G
    Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
    [No Abstract]   [Full Text] [Related]  

  • 84. [Cytostatic therapy of malignant testicular tumors].
    Wilms K
    Minerva Med; 1973 Mar; 64(14):666-9. PubMed ID: 4122503
    [No Abstract]   [Full Text] [Related]  

  • 85. [Results of chemotherapy with cisplatin, pepleomycin and adriamycin (PPA therapy) in testicular cancer].
    Kameyama S; Fujita K; Murayama T; Sugimoto M; Kawamura M; Sayama T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jun; 78(6):1011-7. PubMed ID: 2446039
    [No Abstract]   [Full Text] [Related]  

  • 86. Significant factors in the optimal management of advanced stage germ cell carcinoma.
    Levi JA; Aroney RS; Dalley DN
    Aust N Z J Med; 1982 Apr; 12(2):147-52. PubMed ID: 6178393
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 89. [Therapy of germinal testicular tumors].
    Peters HJ
    Dtsch Med Wochenschr; 1977 Jul; 102(26):968-9. PubMed ID: 885078
    [No Abstract]   [Full Text] [Related]  

  • 90. Review of etoposide single-agent activity.
    Schmoll H
    Cancer Treat Rev; 1982 Jun; 9 Suppl():21-30. PubMed ID: 6751532
    [No Abstract]   [Full Text] [Related]  

  • 91. [Cytostatic therapy of malignant testicular neoplasms].
    Vahlensieck W
    Dtsch Med Wochenschr; 1972 Jan; 97(4):133-4. PubMed ID: 5008212
    [No Abstract]   [Full Text] [Related]  

  • 92. Podophyllotoxin derivative VP 16-213.
    Arnold AM
    Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Wakui A; Yokoyama M; Takahashi H; Yoshida Y; Sakata Y; Sato S; Kano A; Kawamoto K; Hashimoto S; Konno K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phase II study of etoposide in the treatment of esophageal carcinoma.
    Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
    Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
    [No Abstract]   [Full Text] [Related]  

  • 95. Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents.
    Edmonson JH; Decker DG; Malkasian GD; Webb MJ; Jorgensen EO
    Gynecol Oncol; 1978 Feb; 6(1):7-9. PubMed ID: 620951
    [No Abstract]   [Full Text] [Related]  

  • 96. [Testicular tumors--a breakthrough?].
    Schmidt CG
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1293-300. PubMed ID: 6635628
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A chemotherapeutic approach to advanced testicular carcinoma.
    Wyatt JK; McAninch LN
    Can J Surg; 1967 Oct; 10(4):421-6. PubMed ID: 6070298
    [No Abstract]   [Full Text] [Related]  

  • 98. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
    Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
    Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
    [No Abstract]   [Full Text] [Related]  

  • 99. [Combined radiological and cytostatic therapy of testicular tumors].
    Stoll W; Arndt J
    Radiobiol Radiother (Berl); 1970; 11(5):591-5. PubMed ID: 5509225
    [No Abstract]   [Full Text] [Related]  

  • 100. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
    Kroner T; Obrecht JP; Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.